(19)
(11) EP 1 185 290 A1

(12)

(43) Date of publication:
13.03.2002 Bulletin 2002/11

(21) Application number: 00942627.1

(22) Date of filing: 06.06.2000
(51) International Patent Classification (IPC)7A61K 38/12, A61K 35/14, C07K 16/00, C12N 7/04, C12N 7/06
(86) International application number:
PCT/US0011/870
(87) International publication number:
WO 0076/534 (21.12.2000 Gazette 2000/51)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 15.06.1999 US 333289

(71) Applicant: ALPHA THERAPEUTIC CORPORATION
Los AngelesCalifornia 90032 (US)

(72) Inventors:
  • MAMIDI, Raja, R.
    Pomona, CA 91776 (US)
  • BAGDASARIAN, Andranik
    San Dimas, CA 91773 (US)
  • CANAVERAL, Gorgonio
    Walnut, CA 91789 (US)

(74) Representative: Albrecht, Thomas, Dr. 
Kraus, Weisert & PartnerPatent- und RechtsanwälteThomas-Wimmer-Ring 15
80539 München
80539 München (DE)

   


(54) MANUFACTURING METHOD FOR INTRAVENOUS IMMUNE GLOBULIN AND RESULTANT PRODUCT